We are live on ! Find out more
GLSI icon

Greenwich LifeSciences
GLSI

42 hedge funds and large institutions have $13.3M invested in Greenwich LifeSciences in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 6

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

8% more funds holding

Funds holding: 39 → 42 (+3)

0.31% more ownership

Funds ownership: 8.67% → 8.98% (+0.31%)

19% less capital invested

Capital invested by funds: $16.4M → $13.3M (-$3.13M)

Holders
42
Holders Change
+3
Holders Change %
+7.69%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
16
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$202K
2
Northern Trust
Northern Trust
Illinois
+$173K
3
BlackRock
BlackRock
New York
+$103K
4
SO
STRS Ohio
Ohio
+$77.6K
5
JP Morgan Chase
JP Morgan Chase
New York
+$59.8K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$153K
2
Renaissance Technologies
Renaissance Technologies
New York
-$131K
3
Morgan Stanley
Morgan Stanley
New York
-$43.6K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$5.94K
5
CF
Corebridge Financial
Texas
-$2.17K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$11.8K +$5.56K +415 +66%
Legal & General Group
27
Legal & General Group
United Kingdom
$7.43K – – –
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$7K -$5.94K -444 -41%
AIP
29
Ameritas Investment Partners
Nebraska
$6.57K – – –
FCMT
30
Founders Capital Management (Texas)
Texas
$5.62K – – –
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$4.86K – – –
WTA
32
Washington Trust Advisors
Massachusetts
$2.25K – – –
AB
33
Amalgamated Bank
New York
$2K – – –
Fidelity Investments
34
Fidelity Investments
Massachusetts
$1.53K -$388 -29 -18%
FDCDDQ
35
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.12K – – –
GWM
36
Geneos Wealth Management
Colorado
$988 – – –
NSIM
37
North Star Investment Management
Illinois
$573 – – –
HFS
38
Hopwood Financial Services
Virginia
$562 +$669 +50 New
GRP
39
Global Retirement Partners
California
$505 +$187 +14 +45%
SS
40
SBI Securities
Japan
$337 +$402 +30 New
SCM
41
Sterling Capital Management
North Carolina
$67 – – –
Millennium Management
42
Millennium Management
New York
– -$153K -10,638 Closed
Carson Wealth (CWM LLC)
43
Carson Wealth (CWM LLC)
Nebraska
– -$254 -19 -63%
CPA
44
Capital Performance Advisors
California
– -$14 -1 Closed
1
2

GLSI Hedge Fund Activity: Q4 2024 in Review

42 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q4 2024, worth a combined $13.3M — down 19% from $16.4M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new GLSI positions and 3 closed out — a net gain of 3 holders — while 16 added to existing stakes and 6 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $202K. The largest seller was Millennium Management, exiting entirely with an estimated $153K sold.

  • 42 institutional investors held Greenwich LifeSciences (GLSI) as of Q4 2024, up from 39 in Q3 2024.
  • Funds reported $13.3M of Greenwich LifeSciences stock for Q4 2024, down 19% quarter-over-quarter.
  • 6 funds opened new Greenwich LifeSciences positions in Q4 2024 and 3 closed out, a net change of +3 holders.
  • The largest Greenwich LifeSciences buyer in Q4 2024 was Goldman Sachs, an estimated $202K added.
  • The largest Greenwich LifeSciences seller in Q4 2024 was Millennium Management, an estimated $153K sold.

Based on aggregated 13F filings for Q4 2024.